Overall survival results for trifluridine/tipiracil plus bevacizumab vs capecitabine plus bevacizumab: Results from the phase 3 SOLSTICE study.

Thierry André, Alfredo Falcone, Yaroslav V. Shparyk, Fedor Vladimirovich Moiseenko, Eduardo Polo, Tibor Csöszi, Arinilda Silva Campos Bragagnoli, Gabor Liposits, Ewa Chmielowska, Flore Delaporte, Hasnaa Hassan, Donia Skanji, Nadia Amellal, Mark P Saunders

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Fingerprint

Dive into the research topics of 'Overall survival results for trifluridine/tipiracil plus bevacizumab vs capecitabine plus bevacizumab: Results from the phase 3 SOLSTICE study.'. Together they form a unique fingerprint.

Medicine & Life Sciences